CIK 0001583648
- Non-accelerated filer
- Smaller reporting company
PALVELLA THERAPEUTICS, INC.
Sign in to watch- Ticker
- PVLA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 300784346
- Phone
- +1 484-253-1461
- Business address
- 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,725,861
- in 7 filings, $11.7M under 10b5-1 plans
Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 9 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise | +47 | $5.64 | $265 | 66,790 |
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Sale | −146,243 | $5.70 | $834K | 7,194,222 |
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Sale | −1,392 | $5.70 | $8K | 65,398 |
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −27,241 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −259 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −5,227 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −50 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −6,654 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −63 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −8,717 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −83 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −10,180 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −97 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −19,811 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −189 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −8,097 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −77 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −9,642 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −92 | 0 | ||
| 2017-12-18 | ORBIMED ADVISORS LLC 10% owner | Option exercise · Stock Option (right to buy) | −10,182 | 0 |
Page 18 of 21 · 412 trades